Use of multi-color flow cytometry for canine immune cell characterization in cancer

Abstract

Although immunotherapy is becoming a standard approach of human cancer treatment, only a small but critical fraction of patients responds to the therapy. It is therefore required to determine the sub-populations of patients who will respond to immunotherapies along with developing novel strategies to improve efficacy of anti-tumor immune reactions. Current development of novel immunotherapies relies heavily on mouse models of cancer. These models are important for better understanding of mechanisms behind tumor immune escape and investigation of novel strategies to overcome it. Nevertheless, the murine models do not necessarily represent the complexity of spontaneously occurring cancers in humans. Dogs spontaneously develop a wide range of cancer types with an intact immune system under similar environment and exposure to humans, which can serve as translational models in cancer immunotherapy research. To date though, there is still a relatively limited amount of information regarding immune cell profiles in canine cancers. One possible reason could be that there are hardly any established methods to isolate and simultaneously detect a range of immune cell types in neoplastic tissues. To date only a single manuscript describes characterization of immune cells in canine tumour tissues, concentrating solely on T-cells. Here we describe a protocol for multi-color flow cytometry to distinguish immune cell types in blood, lymph nodes, and neoplastic tissues from dogs with cancer. Our results demonstrate that a 9-color flow cytometry panel enables characterization of different cell subpopulations including myeloid cells. We also show that the panel allows detection of minor/aberrant subsets within a mixed population of cells in various neoplastic samples including blood, lymph node and solid tumors. To our knowledge, this is the first simultaneous immune cell detection panel applicable for solid tumors in dogs. This multi-color flow cytometry panel has the potential to inform future basic research focusing on immune cell functions in translational canine cancer models.

Cancer Stem Cell and Epithelial Mesenchymal Transition (EMT) in Canine Transmissible Venereal Tumour- A Preliminary Study

“…Dogs were treated with vincristine (0.025 mg/kg for 3-6 weeks) with palliative care at client owner's residence. Surgically excised tumor samples were processed for flow cytometry analysis as per the prescribed protocol (Zayas et al, 2019;Parys et al, 2023). Following amount of antibody and conjugates were used as surface marker for CSC and EMT identification in the flow cytometry machine (BD LSR Fortessa™ X-20 machine): CD24 PE-IgG1 mouse=10 µg/ml= 8 µL.…”

Safety profile and effects on the peripheral immune response of fecal microbiota transplantation in clinically healthy dogs

“…Staining protocols were used as previously described. [54][55][56] When possible, a minimum of 1 million cells were stained for PBMC. For all experiments, cells were stained for viability with a fixable viability dye Antibodies staining for cell surface markers were directed against cluster of differentiation (CD) 45, CD4, CD8α, and CD25.…”